whitepaper

Application note: A Simoa Pharmacokinetic Bridging Assay

Posted: 19 November 2019 | | No comments yet

Pharmacokinetics (PK) refers to the movement of a drug through the body. The distribution, absorption, metabolism, and excretion of a drug are all important pharmacokinetic factors to be considered in the development of therapeutics.

The ability to detect and quantify the concentration of a therapeutic molecule with high sensitivity may be necessary for effective pharmacokinetic studies, especially if the drug is administered at a low dose. Here we describe a proof of concept assay to demonstrate the Simoa platform as a tool for measuring concentration of the biotherapeutic IgG Adalimumab (Humira®). A sandwich ELISA was created using anti Adalimumab antibodies as capture and detection.To compare performance, equivalent assays were run with the Simoa platform and a standard plate based ELISA.











To read this Application note in full, please complete the form below. By clicking submit you confirm that you accept our terms and conditions and privacy policy.


*

*

*

*

*

*

*

*

This content is provided to you for free thanks to the kind support of our sponsor: Quanterix

Related topics
,

Related organisations

Send this to a friend